Literature DB >> 16985104

Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.

Hyo Soon Lim1, Yong Yeon Jeong, Heoung Keun Kang, Jae Kyu Kim, Jin Gyoon Park.   

Abstract

OBJECTIVE: The purpose of this pictorial essay is to show the imaging features of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) and radiofrequency thermal ablation on CT, MRI, and contrast-enhanced sonography and to describe the advantages and limitations of each imaging technique in evaluating the therapeutic effect on HCC.
CONCLUSION: CT is the standard imaging technique for monitoring the effectiveness of TACE and radiofrequency ablation. Contrast-enhanced sonography and MRI can complement CT in evaluating the therapeutic response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16985104     DOI: 10.2214/AJR.04.1932

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.

Authors:  Nikolaus Kohles; Dorothea Nagel; Dietrich Jüngst; Jürgen Durner; Petra Stieber; Stefan Holdenrieder
Journal:  Tumour Biol       Date:  2011-09-20

Review 2.  Imaging of ocular melanoma metastasis.

Authors:  Rashmi Balasubramanya; Santosh Kumar Selvarajan; Mougnyan Cox; Ganesh Joshi; Sandeep Deshmukh; Donald G Mitchell; Patrick O'Kane
Journal:  Br J Radiol       Date:  2016-05-31       Impact factor: 3.039

Review 3.  Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

Authors:  Anum Aslam; Amita Kamath; Bradley Spieler; Mark Maschiocchi; Carl F Sabottke; Victoria Chernyak; Sara C Lewis
Journal:  Abdom Radiol (NY)       Date:  2021-04-15

Review 4.  Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.

Authors:  Jonathon Willatt; Kevin K Hannawa; Julie A Ruma; Timothy L Frankel; Dawn Owen; Pranab M Barman
Journal:  World J Hepatol       Date:  2015-02-27

5.  Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.

Authors:  Davide Ippolito; Pietro-Andrea Bonaffini; Laura Ratti; Laura Antolini; Rocco Corso; Ferruccio Fazio; Sandro Sironi
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

6.  Intra-operative ultrasound elasticity imaging for monitoring of hepatic tumour thermal ablation.

Authors:  Mark G Van Vledder; Emad M Boctor; Lia R Assumpcao; Hassan Rivaz; Pezhman Foroughi; Gregory D Hager; Ulrike M Hamper; Timothy M Pawlik; Michael A Choti
Journal:  HPB (Oxford)       Date:  2010-12       Impact factor: 3.647

Review 7.  MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review.

Authors:  Mishal Mendiratta-Lala; William R Masch; Kimberly Shampain; Andrew Zhang; Alexandria S Jo; Sarah Moorman; Anum Aslam; Katherine E Maturen; Matthew S Davenport
Journal:  Radiol Imaging Cancer       Date:  2020-01-31

Review 8.  Current role of ultrasound for the management of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaharu Yoshikawa; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.

Authors:  Nikolaus Kohles; Dorothea Nagel; Dietrich Jüngst; Petra Stieber; Stefan Holdenrieder
Journal:  Tumour Biol       Date:  2012-09-11

10.  DYNA CT arteriographic evaluation of hepatocellular carcinoma for treatment by trans-catheter arterial chemoembolization.

Authors:  Caoye Wang; Qi Wang; Wenhua Chen; Zhongming He; Yuanquan Huang; Yifeng Lu; Yi Miao
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.